3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
110
Lymphoid
110
Myeloid
5
Sarcoma
4
Plasma cell
3
Genitourinary
3
Classical hematology
3
Gastrointestinal
2
Dermatologic
2
Breast
2
Thoracic
1
Head & Neck
1
CNS
1
Conditions
Neuroblastoma
44
Ganglioneuroblastoma
6
Brain Neoplasms
6
Sarcoma
5
Neoplasms
5
Glioma
5
Glioblastoma
5
Central Nervous System Neoplasms
3
Astrocytoma
3
Optic Nerve Glioma
2
Oligodendroglioma
2
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Bone Neoplasms
2
Wilms Tumor
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Interventions
Psychiatric Rehabilitation
7
Cyclophosphamide
7
Melphalan
6
Radiotherapy
5
Methylprednisolone
5
Flow Cytometry
5
Busulfan
5
Therapeutics
4
Filgrastim
4
sargramostim
3
Topotecan
3
Rituximab
3
Polymerase Chain Reaction
3
Early Intervention, Educational
3
Drug Therapy
3
Dexamethasone
3
Caspofungin
3
Calcium Dobesilate
3
Antilymphocyte Serum
3
venetoclax
2
thymoglobulin
2
tanespimycin
2
liposomal amphotericin B
2
fludarabine
2
Vorinostat
2
Voriconazole
2
Thiotepa
2
Peripheral Blood Stem Cell Transplantation
2
Ondansetron
2
Methylphenidate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Doxorubicin
×
CNS
×
Clear all
NCT01095926
2013-06-28
Doxo
University Hospital Muenster
Phase 2
Completed
101 enrolled